Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2024 Earnings Call Transcript
Operator: Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (ORGO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 12,484,876 | $39,951,603 | +6% | 2.51% |
| 2. | AQR Capital Management Cliff Asness | 1,522,154 | $4,870,893 | -44% | 0% |
| 3. | Renaissance Technologies Jim Simons | 1,073,500 | $3,435,200 | +32% | 0% |
| 4. | D E Shaw D. E. Shaw | 737,443 | $2,359,818 | -1% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 489,000 | $1,564,800 | -11% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.56 | 3,000 | Large Shareholder | 76,382 | 2022-11-21 | Filing | |
| $2.57 | 3,000 | Large Shareholder | 73,382 | 2022-11-18 | Filing | |
| $4.76 | 3,000 | Director | 70,854 | 2022-08-12 | Filing | |
| $4.80 | 5,000 | Director | 25,547 | 2022-08-12 | Filing | |
| $6.10 | 3,000 | Large Shareholder | 70,382 | 2022-05-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.10 | 25,000 | Director | 166,879 | 2025-03-04 | Filing | |
| $3.49 | 5,585 | Officer, Director | 3,039,194 | 2024-12-16 | Filing | |
| $3.36 | 55,615 | Officer, Director | 3,044,779 | 2024-12-13 | Filing | |
| $3.55 | 43,359 | Officer, Director | 3,100,394 | 2024-12-12 | Filing | |
| $3.64 | 157,448 | Officer, Director | 3,143,753 | 2024-12-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 336,963 | $1,455,680 | 0% | |
| 2. | 112,385 | $485,494 | 0% | |
| 3. | 43,398 | $187,480 | 0% | |
| 4. | 38,666 | $167,038 | 0.06% | |
| 5. | 23,456 | $101,330 | 0% |
News See All
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2024 Earnings Call Transcript
Operator: Please stand by. Welcome ladies and gentlemen to the Third Quarter of Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2024 Earnings Call Transcript
Operator: Please stand by. Welcome ladies and gentlemen to the Second Quarter 2024 Earnings Conference Call for Organogenesis Holdings Inc.
10 Best NASDAQ Penny Stocks To Invest In
Penny stocks are companies that are trading under $5 per share. They represent a unique and controversial segment of the financial market.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript
Organogenesis Holdings Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript
Operator: Welcome ladies and gentlemen to the Fourth Quarter and Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions].
12 Best Micro Cap Stocks To Invest In
In this piece, we will take a look at the 12 best micro cap stocks to invest in.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Second Quarter of Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions].
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen to the First Quarter of Fiscal Year 2023 Earnings Conference Call for the Organogenesis Holdings Inc.
Billionaire Hedge Funds
